MorphoSys concludes capital increase

Monday 19 July 2021


MorphoSys AG has increased its share capital with the issue of 1,337,552 new ordinary shares to a subsidiary of Royalty Pharma Plc as part of a long-term financial partnership that is enabling the German company to acquire Constellation Pharmaceuticals Inc of the US.

Read in full with a subscription

Learn more about subscribing to MedNous.